Current Signal Transduction Therapy
Title:Recent Drug Targets Associated to Abnormal Signal Transduction Mediated Cancer, Rheumatoid Arthritis, Alzheimer’s and Parkinson’s disease
Volume: 14 Issue: 2
Author(s): Sisir Nandi
Affiliation:
Export Options
About this article
Cite this article as:
Nandi Sisir , Recent Drug Targets Associated to Abnormal Signal Transduction Mediated Cancer, Rheumatoid Arthritis, Alzheimer’s and Parkinson’s disease, Current Signal Transduction Therapy 2019; 14 (2) . https://dx.doi.org/10.2174/157436241402191010111824
DOI https://dx.doi.org/10.2174/157436241402191010111824 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
In Vivo Space Radiation-Induced Non-Targeted Responses: Late Effects on Molecular Signaling in Mitochondria
Current Molecular Pharmacology Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery Inflammation, Atrial Fibrillation and Cardiac Surgery: Current Medical and Invasive Approaches for the Treatment of Atrial Fibrillation
Current Pharmaceutical Design Relationship between Inflammatory Mediators, Aβ Levels and ApoE Genotype in Alzheimer Disease
Current Alzheimer Research Novel Tyrosine Kinase Inhibitors in the Treatment of Cancer
Current Drug Targets Endothelial Progenitor Cells as a Therapeutic Approach for Intracerebral Hemorrhage
Current Pharmaceutical Design Cerebrovascular Damage as a Cause for Alzheimers Disease
Current Neurovascular Research Biochemical Markers of Autoimmune Diseases of the Nervous System
Current Pharmaceutical Design Analysis of the Epigenetic Signature of Cell Reprogramming by Computational DNA Methylation Profiles
Current Bioinformatics A Review of Recent Patents on the ASICs as a Key Drug Target
Recent Patents on Biotechnology (Phospho)lipid-based Nanosystems for Skin Administration
Current Pharmaceutical Design Complex Effect of Adenovirus Early Region Proteins on Innate Immune System
Inflammation & Allergy - Drug Targets (Discontinued) The Effects of Psychological Stress on Depression
Current Neuropharmacology Topical Capsaicin for the Treatment of Neuropathic Pain
Current Drug Metabolism Circulating Aminopeptidase Activities in Men and Women with Essential Hypertension
Current Medicinal Chemistry Vitamin D and the Adaptive Immune System with Special Emphasis to Allergic Reactions and Allograft Rejection
Inflammation & Allergy - Drug Targets (Discontinued) Quilizumab is an Afucosylated Humanized Anti-M1 Prime Therapeutic Antibody
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Chronic Tendon Pain-Implications for Treatment: An Update
Current Drug Targets Novel Mast Cell-Stabilising Amine Derivatives of 3,4-Dihydronaphthalen-1(2H)-one and 6,7,8,9-Tetrahydro-5H-benzo[7]annulen-5-one
Medicinal Chemistry Polyphenols and Depression: from Chemistry to Medicine
Current Pharmaceutical Biotechnology